Logo of Neuosmed Pharmacia Pvt Ltd
B-155, G/F DDA SHED Okhla Industrial Estate Phase I New Delhi, 110020, India

contact@neuosmedpharmacia.com

+91-9958003790

Respiratory Care

Home Respiratory Care
According to the World Health Organization (WHO), COPD is the third leading cause of death, responsible for about 3.23 million deaths annually. This accounts for approximately 6% of all deaths globally.

Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. Research on COPD covers various aspects including epidemiology, pathophysiology, diagnosis, treatment, and prevention. Below is an overview of major topics in current COPD studies:

1. Epidemiology and Risk Factors Prevalence: COPD is a major cause of morbidity and mortality globally, with a higher prevalence in older adults. Studies often explore the regional variations in prevalence due to different risk exposures. Smoking and Environmental Exposure: Cigarette smoking is the primary risk factor for COPD. Research also focuses on occupational exposures, air pollution, and exposure to biomass smoke, particularly in low- and middle-income countries. Genetic Predisposition: Studies examine genetic risk factors such as alpha-1 antitrypsin deficiency, which can predispose individuals to COPD even without smoking.

2. Pathophysiology and Mechanisms Inflammation and Oxidative Stress: COPD involves chronic inflammation of the airways, with ongoing research on the role of oxidative stress and inflammatory mediators in disease progression. Airway Remodeling: Studies investigate the structural changes in the airways and alveoli, including emphysema (destruction of alveolar walls) and chronic bronchitis (inflammation of bronchial tubes). Microbiome: Emerging research suggests that the lung microbiome plays a role in exacerbations and disease progression.

3. Diagnosis and Screening Spirometry: Spirometry remains the gold standard for diagnosing COPD, measuring airflow obstruction. Recent studies aim to refine diagnostic criteria, particularly for early-stage disease. Biomarkers: Research is ongoing to identify blood and sputum biomarkers (e.g., eosinophils, CRP) that can help in diagnosing, predicting exacerbations, and guiding treatment decisions. Imaging Studies: Advanced imaging techniques like CT scans and MRI are being explored for assessing structural changes in the lungs.

A doctor doing check-up of a COPD patient.

Get In Touch

B-155, G/F DDA SHED Okhla Industrial Estate Phase I New Delhi, 110020, India

contact@neuosmedpharmacia.com

+91-9958003790

Follow Us

© Neuosmed Pharmacia Pvt Ltd. All Rights Reserved.